Ledger.Open graph →
SEC Form D · filed January 6, 2022

Lucy Therapeutics, Inc

Offering
$20.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

John Ripple · Cambridge, MADirectorAmy Ripka · Cambridge, MAExec · DirectorAnn G. Dewitt · Cambridge, MADirectorKaroly Nikolich · Emerald Hills, CADirectorBreellen Loughlin · Fitchburg, WIExec · DirectorKarin L. Brotman · San Francisco, CADirectorSallie C. Squires · San Francisco, CADirectorJorge Olson · San Diego, CAExec · DirectorNeville Pearson · San Diego, CADirectorSandro Piancone · San Diego, CADirectorKaroly Nikolich · Woburn, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗